Y+LAT1 inhibitors represent a class of compounds that modulate the activity of the y+L amino acid transporter 1, a protein responsible for the facilitated transport of neutral amino acids across cell membranes. This transporter operates by exchanging extracellular, positively charged amino acids (like arginine) for neutral amino acids within the cell in a sodium-independent manner. Inhibitors of this transporter typically function by competitively or noncompetitively interacting with the substrate recognition sites on the transporter, effectively blocking the uptake of amino acids into cells. Since y+LAT1 plays a crucial role in maintaining amino acid homeostasis in cells, the modulation of this transporter by chemical inhibitors can influence cellular amino acid levels and, consequently, a variety of metabolic processes.
The structural diversity of y+LAT1 inhibitors is vast, encompassing a range of chemical entities from simple amino acid derivatives to more complex heterocyclic compounds. Many y+LAT1 inhibitors are designed to mimic the structure of natural substrates, thereby competing with these substrates for binding to the transporter. For instance, certain amino acid analogs can act as competitive inhibitors by occupying the substrate binding site on y+LAT1 without being transported, thus preventing the actual substrates from accessing the transporter. On the other hand, some inhibitors might interact with allosteric sites, inducing conformational changes in the transporter that reduce its affinity for substrates or impair the transport mechanism. The effectiveness of these inhibitors can be influenced by their concentration, the presence of competing substrates, and the specific cellular context in which y+LAT1 is operating. As with all transport inhibitors, the specificity and selectivity of y+LAT1 inhibitors are critical for their utility in research, as off-target effects can complicate the interpretation of results from experimental studies focusing on amino acid transport and metabolism.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
(S)-(+)-N-Benzylserine | 17136-45-7 | sc-220044 | 1 g | $205.00 | 1 | |
A false substrate and competitive inhibitor for neutral amino acid transporters. | ||||||
L-Glutamic acid γ-(p-nitroanilide) hydrochloride | 67953-08-6 | sc-211703 sc-211703A sc-211703B sc-211703C | 500 mg 1 g 5 g 25 g | $71.00 $131.00 $449.00 $1541.00 | 4 | |
Selective inhibitor for system L amino acid transporters, though more specific to LAT1 than y+LAT1. | ||||||
Gabapentin | 60142-96-3 | sc-201481 sc-201481A sc-201481B | 20 mg 100 mg 1 g | $52.00 $92.00 $132.00 | 7 | |
Originally developed as a GABA analog, it also inhibits system L amino acid transporters, though with lower affinity. | ||||||
L-3,3′,5-Triiodothyronine, free acid | 6893-02-3 | sc-204035 sc-204035A sc-204035B | 10 mg 100 mg 250 mg | $40.00 $75.00 $150.00 | ||
A thyroid hormone that can regulate amino acid transporter expression, potentially reducing transporter activity. | ||||||
1-Aminocyclopentanecarboxylic acid | 52-52-8 | sc-202392 | 1 g | $23.00 | ||
A non-metabolizable amino acid that may act as a competitive inhibitor of certain amino acid transporters. | ||||||
Melphalan | 148-82-3 | sc-204799 sc-204799A | 100 mg 250 mg | $136.00 $237.00 | 5 | |
An alkylating agent which is also a substrate for some amino acid transporters and could potentially inhibit y+LAT1. | ||||||